John Jay Treanor, M.D.

Contact Information

Phone Numbers

Office: (585) 275-5871

Fax: (585) 442-9328

Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 689
Rochester, NY 14642

Faculty Appointments

Professor (Part-Time) - Department of Medicine , Infectious Diseases (SMD)

Biography

Professional Background

Dr. Treanor is a graduate of the University of Rochester Medical School and a residency in Internal Medicine at the University of Vermont. He returned to the University of Rochester for Fellowship in Infectious Diseases and also trained at the Laboratory of Infectious Diseases, NIH. Dr. Treanor primarily sees inpatients with general ID problems at UR Medicine and has a small outpatient clinic.

Research

My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention of pandemic influenza, and studies to document and evaluate the priming effects of pandemic vaccines on subsequent booster vaccines. As director of the New York Influenza Center of Excellence, I collaborate with colleagues in microbiology and immunology to perform detailed evaluations of the human humoral and cellular immune responses to influenza infection and vaccination. Our group is also active in clinical trials to evaluate new vaccines for Norovirus and other viral pathogens in the field and in the human experimental infection model.

Credentials

Education

1975
BA | Canisius College
Biology

1979
MD | Univ Rochester Sch Med/Dent
Medicine

Post-doctoral Training & Residency

07/01/1982 - 06/30/1985
Fellowship in Infectious Disease at Univ. of Rochester School of Medicine and Dentistry

07/01/1980 - 07/31/1982
Residency in Internal Medicine at Medical Center Hospital of Vermont

06/01/1979 - 06/30/1980
Internship in Internal Medicine at Medical Center Hospital of Vermont

VIEW ALL

Patents

Patent Title: Modified Phage for Displaying Post-Translationally Modified Proteins and Uses Thereof
Patent #: 8,754,015
Issue Date: Jun 17, 2014
Country: United States
Invented By: Stephen Dewhurst, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: 2,918,739
Issue Date: Sep 07, 2021
Country: Canada
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: ZL201480045309.0
Issue Date: Apr 28, 2020
Country: China, People's Republic of
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: 3022298
Issue Date: Jun 19, 2019
Country: Europe
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: FR3022298
Issue Date: Jun 19, 2019
Country: France
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: 602014048
Issue Date: Jun 19, 2019
Country: Germany
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: GB3022298
Issue Date: Jun 19, 2019
Country: United Kingdom
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: 10,323,231
Issue Date: Jun 18, 2019
Country: United States
Invented By: Andrew Cox, Stephen Dewhurst, John J Treanor

Patent Title: Attenuated Influenza Vaccines and Uses Thereof
Patent #: 9,878,032
Issue Date: Jan 30, 2018
Country: United States
Invented By: Andrew Cox, Stephen Dewhurst, Baek Kim, John J Treanor

VIEW ALL

Publications

Journal Articles

3/12/2018
Nogales A, Piepenbrink MS, Wang J, Ortega S, Basu M, Fucile CF, Treanor JJ, Rosenberg AF, Zand MS, Keefer MC, Martinez-Sobrido L, Kobie JJ. "A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody." Scientific reports.. 2018 Mar 12; 8(1):4374. Epub 2018 Mar 12.

11/21/2017
Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. "Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains." Proceedings of the National Academy of Sciences of the United States of America.. 2017 Nov 21; 114(47):12578-12583. Epub 2017 Nov 06.

5/2017
Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL. "B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine." Clinical and vaccine immunology : CVI.. 2017 May; 24(5)Epub 2017 May 05.

VIEW ALL PUBLICATIONS